The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time

The biotech Moderna has skyrocketed to global prominence, leading the world's race for a coronavirus vaccine.
The Cambridge, Massachusetts-based biotech was founded in 2010 with the ambitious goal to develop a new type of medicine. While its platform remains unproven, it is now being tested under the brightest possible spotlight of a pandemic.
Here's the inside story of Moderna's rise, from an offshoot of stem cell research to routinely shattering funding records on its way to biotech's top ranks.
The biotech has spent a decade working to meet this moment, and investors have sent its stock...Read more ...

Just over half of Americans would definitely get vaccinated against the coronavirus, a new survey found

Only half of Americans say they would get vaccinated against the novel coronavirus, if and when a vaccine becomes available, according to a new YouGov survey.
Another 26% said they were unsure about getting innoculated, while one in five said that they not get vaccinated at all.
The poll comes at a time where more than 100 potential coronavirus vaccines in development and health experts are emphasizing that a vaccine will be needed to return life to normal.
The sentiments echo another more recent survey by Reuters , which shows that a quarter of Americans have little or no interest in...Read more ...